11 completed. 11 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 11 |
| Phase 3 | 2 | Completed 2 |
Follow Deep Vein Thrombosis: new trials by email Literature Review of Deep Vein Thrombosis trials Research Report on Deep Vein Thrombosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma Enoxaparin - Venous Thromboembolism, Deep Vein Thrombosis | Phase 2 | Completed | University of Utah | 80 | 2017-11-15 | 2024-01-31 |
| A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis edoxaban tosylate, enoxaparin/unfractionated heparin, warfarin - Deep Vein Thrombosis, Venous Thrombosis | Phase 2 | Completed | Daiichi Sankyo | 85 | 2012-08-01 | 2019-02-26 |
| Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) Rosuvastatin, Placebo - Venous Thromboembolism, Deep Vein Thrombosis | Phase 2 | Completed | University of Vermont | 38 | 2012-03-01 | 2018-07-10 |
| Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer Rivaroxaban (Xarelto, BAY59-7939) - Venous Thrombosis, Deep Vein Thrombosis | Phase 2 | Completed | Bayer | 25 | 2009-05-01 | 2015-11-18 |
| A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty DU-176b 15mg, DU-176b 30mg, Enoxaparin sodium 20 mg (=2000IU) - Venous Thromboembolism, Thromboembolism | Phase 2 | Completed | Daiichi Sankyo Co., Ltd. | 264 | 2008-07-01 | 2019-02-25 |
| Prophylactic Anticoagulation for Preventing Deep Vein Thrombosis After Total Hip Arthroplasty prophylactic anticoagulation - Deep Vein Thrombosis | Phase 2 / Phase 3 | Completed | JIANG Qing | 2007-01-01 | 2011-10-12 | |
| A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty DU-176b, Placebo - Venous Thromboembolism, Deep Vein Thrombosis | Phase 2 | Completed | Daiichi Sankyo Co., Ltd. | 523 | 2006-07-01 | 2019-02-25 |
| Odiparcil For The Prevention Of Venous Thromboembolism Odiparcil, Warfarin, Coumadin - Deep Vein Thrombosis, Fibrillation, Atrial | Phase 2 | Completed | GlaxoSmithKline | 961 | 2005-09-01 | 2017-05-02 |
| Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis ThromboView - Deep Vein Thrombosis | Phase 2 | Completed | Agen Biomedical | 94 | 2005-03-01 | 2009-08-24 |
| Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT) Xarelto (Rivaroxaban, BAY59-7939), Enoxaparin/Vitamin K-Antagonist - Venous Thrombosis, Deep Vein Thrombosis | Phase 2 | Completed | Bayer | 613 | 2004-03-01 | 2023-09-07 |
| The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section Tinzaparin - Deep Vein Thrombosis | Phase 2 / Phase 3 | Completed | Ottawa Hospital Research Institute | 30 | 2002-07-01 | 2018-02-07 |
Venous Thrombosis (11) · Venous Thromboembolism (5) · Pulmonary Embolism (4) · Embolism and Thrombosis (3) · Thrombosis (3) · Embolism (2) · Acquired Immunodeficiency Syndrome (1) · Atrial Fibrillation (1) · Cardiovascular Diseases (1) · Hemorrhage (1) · Lung Diseases (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Respiratory Tract Diseases (1) · Thromboembolism (1)
Cardiovascular Diseases (10) · Vascular Diseases (10) · Embolism and Thrombosis (8) · Thrombosis (8) · Thromboembolism (4) · Lung Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Respiratory Tract Diseases (3) · Embolism (2) · Arrhythmias, Cardiac (1) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · HIV Infections (1)
Enoxaparin (3) · edoxaban (3) · Rivaroxaban (2) · Warfarin (2) · Heparin (1) · Rosuvastatin Calcium (1) · Tinzaparin (1) · enoxaparin sodium (1) · odiparcil (1) · thromboview (1)
Bayer (2) · Daiichi Sankyo Co., Ltd. (2) · Agen Biomedical (1) · Daiichi Sankyo (1) · GlaxoSmithKline (1) · JIANG Qing (1) · Ottawa Hospital Research Institute (1) · University of Utah (1) · University of Vermont (1)
Canada (5) · United States (5) · Australia (3) · Brazil (3) · Israel (3) · South Africa (3) · Austria (2) · Germany (2) · Hungary (2) · Italy (2) · Japan (2) · Netherlands (2) · Poland (2) · Belgium (1) · China (1)
Jeff Ginsberg, MD FRCPC (1) · Jim Douketis, MD FRCPC (1) · Marc Rodger, MD (1) · Samuel Z Goldhaber, MD (1) · Steven Ades, MD, MSc (1) · Takeshi Fuji (1) · Takeshi Fuji, Director (1)
PMID 16458642, PMID 25047458, PMID 27165711, PMID 33779986
2004 (1), 2008 (1)